LIB Therapeutics is a biopharmaceutical company focused on cardiovascular disease and familial hypercholesterolemia, developing PCSK9 inhibitors to help patients achieve their LDL-C goals
LIB Therapeutics is a biopharmaceutical company focused on cardiovascular disease and familial hypercholesterolemia, developing PCSK9 inhibitors to help patients achieve their LDL-C goals.